HK1042695A1 - 蛋白酶抑制劑 - Google Patents

蛋白酶抑制劑

Info

Publication number
HK1042695A1
HK1042695A1 HK02102419.7A HK02102419A HK1042695A1 HK 1042695 A1 HK1042695 A1 HK 1042695A1 HK 02102419 A HK02102419 A HK 02102419A HK 1042695 A1 HK1042695 A1 HK 1042695A1
Authority
HK
Hong Kong
Prior art keywords
prothease
inhibitors
prothease inhibitors
Prior art date
Application number
HK02102419.7A
Other languages
English (en)
Chinese (zh)
Inventor
Wells Marquis Robert Jr
Frank Veber Daniel
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1042695A1 publication Critical patent/HK1042695A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16Eight-membered rings
    • C07D313/18Eight-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02102419.7A 1999-02-19 2002-03-28 蛋白酶抑制劑 HK1042695A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12069999P 1999-02-19 1999-02-19
PCT/US2000/004133 WO2000049011A1 (fr) 1999-02-19 2000-02-17 Inhibiteurs de protease

Publications (1)

Publication Number Publication Date
HK1042695A1 true HK1042695A1 (zh) 2002-08-23

Family

ID=22392011

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102419.7A HK1042695A1 (zh) 1999-02-19 2002-03-28 蛋白酶抑制劑

Country Status (8)

Country Link
EP (1) EP1153022A4 (fr)
JP (1) JP2002537297A (fr)
AU (1) AU3235100A (fr)
CO (1) CO5271679A1 (fr)
DZ (1) DZ3083A1 (fr)
HK (1) HK1042695A1 (fr)
PE (1) PE20001486A1 (fr)
WO (1) WO2000049011A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
WO2001034156A1 (fr) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de protease
EP1232154A4 (fr) 1999-11-10 2004-06-23 Smithkline Beecham Corp Inhibiteurs de protease
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
CA2404206A1 (fr) 2000-03-21 2001-09-27 Smithkline Beecham Corporation Inhibiteur de proteinase
WO2002040462A2 (fr) * 2000-11-17 2002-05-23 Medivir Uk Limited Inhibiteurs de cystéine protéase
EP1358183B1 (fr) * 2000-11-17 2006-04-12 Medivir Ab Inhibiteurs de la cysteine protease
EP1482020B1 (fr) * 2003-05-27 2006-09-06 MERCK PATENT GmbH Dérivés de pyrane avec une double liaison exocyclique
ATE340836T1 (de) 2003-05-27 2006-10-15 Merck Patent Gmbh Pyranderivate
EP1757284A1 (fr) * 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Utilisation de la N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) pour la prévention ou le traitement de la dystrophie musculaire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
EP0687249A1 (fr) * 1993-03-03 1995-12-20 Eli Lilly And Company Balanoides
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios

Also Published As

Publication number Publication date
JP2002537297A (ja) 2002-11-05
EP1153022A1 (fr) 2001-11-14
PE20001486A1 (es) 2001-02-08
CO5271679A1 (es) 2003-04-30
EP1153022A4 (fr) 2002-03-27
WO2000049011A1 (fr) 2000-08-24
AU3235100A (en) 2000-09-04
DZ3083A1 (fr) 2004-06-02

Similar Documents

Publication Publication Date Title
GB9900416D0 (en) Inhibitors
IL146518A0 (en) Metalloprotease inhibitors
EG23979A (en) Renin inhibitors
IL148820A0 (en) Fab i inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
EP1153022A4 (fr) Inhibiteurs de protease
EP1235577A4 (fr) Inhibiteurs de protease
GB9924522D0 (en) Enzyme inhibitors
EP1232155A4 (fr) Inhibiteurs de protease
EP1229912A4 (fr) Inhibiteurs de protease
EP1231921A4 (fr) Inhibiteurs de proteases
EP1229915A4 (fr) Inhibiteurs de protease
EP1229914A4 (fr) Inhibiteurs de protease
HK1043534A1 (zh) 蛋白酶抑制劑
EP1173429A4 (fr) Inhibiteurs de protease
EP1229911A4 (fr) Inhibiteurs de proteases
EP1351930A4 (fr) Inhibiteurs de la protease
EP1233771A4 (fr) Inhibiteurs de protease
GB2389113B (en) B-secretase inhibitor
EP1231923A4 (fr) Inhibiteurs de protease
EP1232154A4 (fr) Inhibiteurs de protease
EP1231922A4 (fr) Inhibiteurs de protease
EP1189618A4 (fr) Inhibiteurs de la thrombine
GB9929341D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors